Analysis

A wave of cautious optimism is beginning to emerge for Danish pharmaceutical giant Novo Nordisk following a prolonged period of...

A disastrous quarterly performance has triggered a severe crisis of confidence for semiconductor design specialist Synopsys. While the recent financial...

After months of downward pressure, the life sciences giant Danaher is finally displaying encouraging signals. The critical question for investors...

The U.S. Food and Drug Administration (FDA) has launched a significant regulatory action, placing telehealth company Hims & Hers under...

While Oracle secures unprecedented artificial intelligence contracts valued in the hundreds of billions, a note of caution has emerged from...

While Armour Residential REIT continues its pattern of stable dividend distributions, its stock performance reflects a more turbulent reality, grappling...

Biopharmaceutical company Incyte may be on the verge of a significant advancement for its dermatology division. New long-term results for...

Nuscale Power shares are drawing significant market attention as the company participates in the KeyBanc Taking Charge-Energy Transition Symposium. The...

Eli Lilly has delivered a decisive victory in a head-to-head clinical trial against competitor Novo Nordisk, with results exceeding market...

Adobe Inc. has once again delivered exceptional quarterly results, yet the market response remains puzzlingly muted. The San Jose-based software...